| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pruritus | 30 | 2022 | 359 | 8.110 |
Why?
|
| Insect Proteins | 21 | 2020 | 258 | 2.610 |
Why?
|
| Receptors, G-Protein-Coupled | 9 | 2020 | 1221 | 2.340 |
Why?
|
| Receptors, Neuropeptide | 5 | 2020 | 111 | 2.020 |
Why?
|
| Ganglia, Spinal | 4 | 2017 | 517 | 1.470 |
Why?
|
| Receptors, Proteinase-Activated | 5 | 2015 | 19 | 1.340 |
Why?
|
| Mast Cells | 6 | 2020 | 1544 | 1.330 |
Why?
|
| Cathepsins | 3 | 2015 | 239 | 1.270 |
Why?
|
| Melanophores | 6 | 2009 | 16 | 1.220 |
Why?
|
| Cysteine Proteases | 2 | 2017 | 22 | 1.220 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 11 | 2011 | 52 | 1.160 |
Why?
|
| Mucuna | 3 | 2017 | 6 | 1.070 |
Why?
|
| Vasodilator Agents | 14 | 2011 | 976 | 1.040 |
Why?
|
| Dermatitis, Atopic | 7 | 2022 | 653 | 1.000 |
Why?
|
| Insect Hormones | 9 | 1997 | 75 | 0.960 |
Why?
|
| Psychodidae | 10 | 2020 | 23 | 0.870 |
Why?
|
| Nerve Tissue Proteins | 5 | 2020 | 4465 | 0.850 |
Why?
|
| Substance P | 3 | 2017 | 335 | 0.810 |
Why?
|
| Cysteine Endopeptidases | 2 | 2017 | 563 | 0.760 |
Why?
|
| Interneurons | 2 | 2017 | 576 | 0.760 |
Why?
|
| Gastrin-Releasing Peptide | 2 | 2017 | 38 | 0.740 |
Why?
|
| Spinal Cord | 3 | 2019 | 1807 | 0.730 |
Why?
|
| Leishmaniasis | 4 | 2008 | 46 | 0.730 |
Why?
|
| Sensory Receptor Cells | 4 | 2018 | 487 | 0.720 |
Why?
|
| p-Methoxy-N-methylphenethylamine | 3 | 2020 | 41 | 0.700 |
Why?
|
| Skin | 12 | 2022 | 4353 | 0.650 |
Why?
|
| Dermatology | 4 | 2017 | 870 | 0.650 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2017 | 100 | 0.600 |
Why?
|
| Pyroglyphidae | 1 | 2017 | 87 | 0.590 |
Why?
|
| Diptera | 5 | 2007 | 53 | 0.570 |
Why?
|
| Eczema | 1 | 2018 | 229 | 0.550 |
Why?
|
| HeLa Cells | 7 | 2017 | 3127 | 0.550 |
Why?
|
| Basophils | 1 | 2018 | 389 | 0.540 |
Why?
|
| Trigeminal Ganglion | 1 | 2016 | 186 | 0.530 |
Why?
|
| Peripheral Nervous System | 1 | 2016 | 150 | 0.520 |
Why?
|
| Plant Proteins | 1 | 2017 | 364 | 0.520 |
Why?
|
| Receptors, Pituitary Hormone | 5 | 2002 | 29 | 0.510 |
Why?
|
| Receptor, PAR-2 | 1 | 2014 | 32 | 0.500 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 11 | 2012 | 91 | 0.490 |
Why?
|
| Peripheral Nerves | 1 | 2018 | 474 | 0.480 |
Why?
|
| Dynorphins | 1 | 2014 | 83 | 0.470 |
Why?
|
| Salivary Glands | 7 | 2009 | 228 | 0.470 |
Why?
|
| Posterior Horn Cells | 1 | 2014 | 87 | 0.470 |
Why?
|
| Arginine | 1 | 2017 | 944 | 0.460 |
Why?
|
| Leishmaniasis, Cutaneous | 4 | 2017 | 124 | 0.460 |
Why?
|
| Glutamic Acid | 1 | 2017 | 1167 | 0.400 |
Why?
|
| Ficain | 1 | 2010 | 2 | 0.390 |
Why?
|
| Bromelains | 1 | 2010 | 6 | 0.380 |
Why?
|
| Papain | 1 | 2010 | 64 | 0.380 |
Why?
|
| Nitric Oxide Synthase | 3 | 2017 | 916 | 0.380 |
Why?
|
| Hypersensitivity | 2 | 2017 | 1093 | 0.370 |
Why?
|
| Signal Transduction | 10 | 2018 | 23387 | 0.360 |
Why?
|
| Neural Inhibition | 1 | 2014 | 598 | 0.360 |
Why?
|
| Nitric Oxide | 4 | 2017 | 2128 | 0.360 |
Why?
|
| Skin Diseases | 5 | 2022 | 1065 | 0.360 |
Why?
|
| Animals | 62 | 2022 | 168561 | 0.330 |
Why?
|
| Skin Physiological Phenomena | 3 | 2017 | 180 | 0.320 |
Why?
|
| Cell Degranulation | 3 | 2020 | 287 | 0.320 |
Why?
|
| Salivary Proteins and Peptides | 2 | 2020 | 52 | 0.300 |
Why?
|
| Vasodilation | 5 | 2011 | 944 | 0.300 |
Why?
|
| Wound Healing | 1 | 2018 | 2781 | 0.280 |
Why?
|
| TRPM Cation Channels | 1 | 2007 | 140 | 0.280 |
Why?
|
| Cyclic AMP | 10 | 2009 | 1470 | 0.280 |
Why?
|
| Melanins | 2 | 2007 | 288 | 0.280 |
Why?
|
| Receptors, Melanocortin | 1 | 2005 | 25 | 0.270 |
Why?
|
| Enzyme Activation | 2 | 2010 | 3701 | 0.260 |
Why?
|
| Wounds and Injuries | 1 | 2018 | 2400 | 0.260 |
Why?
|
| HEK293 Cells | 4 | 2020 | 4200 | 0.260 |
Why?
|
| Langerhans Cells | 4 | 2004 | 173 | 0.250 |
Why?
|
| Neurons | 7 | 2019 | 9325 | 0.250 |
Why?
|
| Keratinocytes | 5 | 2016 | 797 | 0.250 |
Why?
|
| Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide | 6 | 2012 | 12 | 0.240 |
Why?
|
| Insect Vectors | 3 | 2017 | 134 | 0.240 |
Why?
|
| Recombinant Proteins | 10 | 2013 | 6608 | 0.240 |
Why?
|
| Cytokines | 3 | 2022 | 7317 | 0.240 |
Why?
|
| Peptide Library | 1 | 2005 | 350 | 0.230 |
Why?
|
| Pain | 2 | 2022 | 4961 | 0.220 |
Why?
|
| Neuropeptides | 5 | 2003 | 942 | 0.200 |
Why?
|
| RNA, Messenger | 3 | 2015 | 13029 | 0.200 |
Why?
|
| Melanocytes | 2 | 2007 | 515 | 0.200 |
Why?
|
| Humans | 64 | 2022 | 742088 | 0.200 |
Why?
|
| Ice | 1 | 2022 | 104 | 0.200 |
Why?
|
| Neurotransmitter Agents | 3 | 2011 | 647 | 0.190 |
Why?
|
| Zebrafish Proteins | 1 | 2007 | 1004 | 0.190 |
Why?
|
| Amino Acid Sequence | 10 | 2014 | 13814 | 0.190 |
Why?
|
| Insect Bites and Stings | 1 | 2020 | 67 | 0.180 |
Why?
|
| Oligopeptides | 1 | 2005 | 1176 | 0.170 |
Why?
|
| Pemphigus | 1 | 2020 | 103 | 0.170 |
Why?
|
| Capsaicin | 2 | 2017 | 229 | 0.170 |
Why?
|
| Xenopus laevis | 5 | 2009 | 956 | 0.170 |
Why?
|
| DNA, Single-Stranded | 1 | 2020 | 353 | 0.170 |
Why?
|
| Brain | 5 | 2016 | 26343 | 0.160 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2017 | 895 | 0.160 |
Why?
|
| Foundations | 1 | 2017 | 94 | 0.150 |
Why?
|
| Leishmania braziliensis | 2 | 1994 | 15 | 0.150 |
Why?
|
| Oligonucleotides | 1 | 2020 | 572 | 0.150 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 2000 | 641 | 0.150 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2017 | 129 | 0.140 |
Why?
|
| Synaptic Transmission | 2 | 2015 | 1179 | 0.140 |
Why?
|
| Vasoactive Intestinal Peptide | 4 | 2009 | 179 | 0.140 |
Why?
|
| Immunocompromised Host | 1 | 2002 | 847 | 0.140 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2000 | 277 | 0.140 |
Why?
|
| Receptors, Bombesin | 1 | 2015 | 27 | 0.140 |
Why?
|
| Histamine | 1 | 2017 | 507 | 0.130 |
Why?
|
| Skin Pigmentation | 2 | 2007 | 281 | 0.130 |
Why?
|
| Plant Extracts | 2 | 2010 | 469 | 0.130 |
Why?
|
| Chloroquine | 1 | 2017 | 280 | 0.130 |
Why?
|
| Inflammation | 4 | 2020 | 10578 | 0.130 |
Why?
|
| Molecular Sequence Data | 11 | 2008 | 18112 | 0.130 |
Why?
|
| Platelet Aggregation | 2 | 2000 | 800 | 0.130 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2015 | 130 | 0.130 |
Why?
|
| Calcitonin Gene-Related Peptide | 5 | 1996 | 305 | 0.120 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2017 | 449 | 0.120 |
Why?
|
| Mice | 21 | 2020 | 81045 | 0.120 |
Why?
|
| Biomedical Research | 1 | 2010 | 3306 | 0.120 |
Why?
|
| Cryotherapy | 1 | 2015 | 154 | 0.120 |
Why?
|
| Neural Crest | 1 | 1996 | 275 | 0.120 |
Why?
|
| Rabbits | 8 | 2017 | 4886 | 0.120 |
Why?
|
| Second Messenger Systems | 1 | 1995 | 206 | 0.120 |
Why?
|
| Sensory Thresholds | 1 | 2015 | 394 | 0.120 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 4751 | 0.120 |
Why?
|
| Biological Evolution | 1 | 2019 | 1074 | 0.110 |
Why?
|
| Tissue Extracts | 1 | 1993 | 135 | 0.110 |
Why?
|
| Receptors, Vasoactive Intestinal Peptide | 3 | 2009 | 9 | 0.110 |
Why?
|
| Cell Line | 5 | 2016 | 15994 | 0.110 |
Why?
|
| Cells, Cultured | 7 | 2017 | 19223 | 0.110 |
Why?
|
| Behavior, Animal | 2 | 2020 | 1882 | 0.110 |
Why?
|
| Nausea | 1 | 2016 | 665 | 0.110 |
Why?
|
| Antibodies | 3 | 2017 | 2459 | 0.110 |
Why?
|
| History, 21st Century | 2 | 2010 | 1533 | 0.110 |
Why?
|
| Muscle, Smooth | 1 | 1996 | 933 | 0.110 |
Why?
|
| Allergens | 2 | 2016 | 1314 | 0.100 |
Why?
|
| Chronic Disease | 2 | 2018 | 9144 | 0.100 |
Why?
|
| Receptors, Interleukin-8A | 1 | 2011 | 44 | 0.100 |
Why?
|
| Cheek | 1 | 2011 | 63 | 0.100 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2011 | 59 | 0.100 |
Why?
|
| Emollients | 1 | 2011 | 33 | 0.100 |
Why?
|
| Quality of Life | 1 | 2013 | 12730 | 0.100 |
Why?
|
| Histamine Antagonists | 1 | 2011 | 93 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2017 | 15108 | 0.100 |
Why?
|
| History, 20th Century | 2 | 2010 | 2739 | 0.100 |
Why?
|
| Adjuvants, Immunologic | 1 | 1996 | 1000 | 0.090 |
Why?
|
| Cell Communication | 1 | 2018 | 1619 | 0.090 |
Why?
|
| Enzyme Inhibitors | 3 | 2017 | 3800 | 0.090 |
Why?
|
| Central Nervous System Diseases | 1 | 2015 | 518 | 0.090 |
Why?
|
| Protein Interaction Mapping | 1 | 2014 | 627 | 0.090 |
Why?
|
| Peptide Hydrolases | 1 | 2013 | 627 | 0.090 |
Why?
|
| Binding, Competitive | 6 | 2001 | 1159 | 0.090 |
Why?
|
| Mice, Inbred BALB C | 8 | 2020 | 6382 | 0.090 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2015 | 700 | 0.090 |
Why?
|
| Administration, Cutaneous | 1 | 2011 | 711 | 0.080 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2000 | 1801 | 0.080 |
Why?
|
| Models, Molecular | 2 | 2017 | 5454 | 0.080 |
Why?
|
| Plant Structures | 1 | 2008 | 6 | 0.080 |
Why?
|
| Carps | 1 | 2008 | 52 | 0.080 |
Why?
|
| Antipruritics | 2 | 2022 | 30 | 0.080 |
Why?
|
| Acupuncture Therapy | 1 | 2012 | 464 | 0.080 |
Why?
|
| Fish Proteins | 1 | 2008 | 46 | 0.080 |
Why?
|
| Central Nervous System | 1 | 2015 | 1354 | 0.080 |
Why?
|
| Phenylthiourea | 1 | 2007 | 11 | 0.080 |
Why?
|
| Capillary Permeability | 1 | 2011 | 798 | 0.080 |
Why?
|
| Leg Ulcer | 1 | 1988 | 69 | 0.080 |
Why?
|
| Water Supply | 1 | 2009 | 214 | 0.080 |
Why?
|
| Dermatologic Agents | 1 | 2011 | 274 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2015 | 5180 | 0.080 |
Why?
|
| Interleukin-6 | 1 | 2017 | 3199 | 0.080 |
Why?
|
| Cryptococcosis | 1 | 1988 | 101 | 0.070 |
Why?
|
| Pyoderma | 1 | 1986 | 8 | 0.070 |
Why?
|
| Pituitary Hormones | 1 | 2008 | 183 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 1996 | 2867 | 0.070 |
Why?
|
| Connecticut | 1 | 2007 | 363 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2000 | 1574 | 0.070 |
Why?
|
| Nervous System Physiological Phenomena | 2 | 1998 | 117 | 0.070 |
Why?
|
| Mice, Transgenic | 2 | 2017 | 9735 | 0.070 |
Why?
|
| Adenosine Diphosphate | 2 | 2000 | 425 | 0.070 |
Why?
|
| Acute Disease | 1 | 2016 | 7141 | 0.070 |
Why?
|
| Antibodies, Antinuclear | 1 | 1987 | 326 | 0.070 |
Why?
|
| Water Pollutants, Chemical | 1 | 2009 | 311 | 0.070 |
Why?
|
| Cloning, Molecular | 4 | 2008 | 4322 | 0.070 |
Why?
|
| Mice, Inbred Strains | 4 | 2004 | 1827 | 0.060 |
Why?
|
| Pituitary Gland | 1 | 2008 | 665 | 0.060 |
Why?
|
| Proteins | 1 | 2000 | 6096 | 0.060 |
Why?
|
| Rats | 8 | 2022 | 24265 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2017 | 10943 | 0.060 |
Why?
|
| T-Lymphocytes | 6 | 1996 | 10163 | 0.060 |
Why?
|
| Nitric Oxide Donors | 1 | 2004 | 121 | 0.060 |
Why?
|
| Leishmaniasis, Mucocutaneous | 2 | 1996 | 12 | 0.060 |
Why?
|
| Male | 26 | 2017 | 349538 | 0.060 |
Why?
|
| Nitroprusside | 1 | 2004 | 275 | 0.060 |
Why?
|
| Protein Structure, Secondary | 1 | 2007 | 1245 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 2 | 2000 | 1799 | 0.060 |
Why?
|
| Embryo, Nonmammalian | 1 | 2007 | 894 | 0.060 |
Why?
|
| Fibrinogen | 2 | 2000 | 894 | 0.060 |
Why?
|
| Chromium | 1 | 2004 | 123 | 0.060 |
Why?
|
| Transfection | 3 | 2002 | 5892 | 0.060 |
Why?
|
| Neural Pathways | 1 | 2014 | 2971 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2006 | 2837 | 0.060 |
Why?
|
| Pigments, Biological | 1 | 2002 | 53 | 0.060 |
Why?
|
| Pyloric Antrum | 1 | 2003 | 68 | 0.060 |
Why?
|
| Cyclic GMP | 2 | 1995 | 408 | 0.050 |
Why?
|
| Epidermis | 2 | 2004 | 527 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 6 | 2016 | 21821 | 0.050 |
Why?
|
| Peptide Fragments | 3 | 2015 | 5095 | 0.050 |
Why?
|
| Enkephalin, Ala(2)-MePhe(4)-Gly(5)- | 1 | 2002 | 36 | 0.050 |
Why?
|
| Ultraviolet Rays | 1 | 2007 | 1059 | 0.050 |
Why?
|
| Spleen | 4 | 1996 | 2359 | 0.050 |
Why?
|
| Freund's Adjuvant | 1 | 2022 | 139 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 4 | 2017 | 6171 | 0.050 |
Why?
|
| Receptor Cross-Talk | 1 | 2002 | 118 | 0.050 |
Why?
|
| Adolescent | 7 | 2017 | 85649 | 0.050 |
Why?
|
| Skin Tests | 2 | 2015 | 612 | 0.050 |
Why?
|
| Molecular Weight | 2 | 1995 | 2255 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2011 | 1847 | 0.050 |
Why?
|
| Immune System | 2 | 1998 | 804 | 0.050 |
Why?
|
| Brain Mapping | 2 | 2014 | 6669 | 0.050 |
Why?
|
| Receptors, Opioid | 1 | 2002 | 155 | 0.050 |
Why?
|
| Atrial Natriuretic Factor | 1 | 2003 | 393 | 0.050 |
Why?
|
| Paresthesia | 1 | 2022 | 162 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 2 | 1996 | 804 | 0.050 |
Why?
|
| Ligands | 1 | 2008 | 3293 | 0.050 |
Why?
|
| Glycoproteins | 2 | 2008 | 2260 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1993 | 3067 | 0.050 |
Why?
|
| Young Adult | 4 | 2017 | 56350 | 0.050 |
Why?
|
| Hypersensitivity, Delayed | 3 | 1996 | 485 | 0.050 |
Why?
|
| Cathelicidins | 1 | 2020 | 80 | 0.050 |
Why?
|
| PC12 Cells | 2 | 1999 | 330 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2004 | 1341 | 0.050 |
Why?
|
| Disease Models, Animal | 7 | 2020 | 18006 | 0.050 |
Why?
|
| Venules | 2 | 2011 | 163 | 0.050 |
Why?
|
| Erythema | 2 | 1992 | 254 | 0.050 |
Why?
|
| Mycoses | 2 | 1997 | 376 | 0.040 |
Why?
|
| Xenopus Proteins | 1 | 2002 | 433 | 0.040 |
Why?
|
| Calcium | 3 | 2010 | 5753 | 0.040 |
Why?
|
| Lymphocyte Culture Test, Mixed | 3 | 1996 | 517 | 0.040 |
Why?
|
| Female | 19 | 2017 | 379592 | 0.040 |
Why?
|
| Naloxone | 1 | 2002 | 367 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2022 | 8300 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 1988 | 2257 | 0.040 |
Why?
|
| Kinetics | 3 | 1999 | 6474 | 0.040 |
Why?
|
| Gene Expression | 3 | 2010 | 7790 | 0.040 |
Why?
|
| Pneumonia | 1 | 2010 | 2117 | 0.040 |
Why?
|
| Research | 1 | 2007 | 1999 | 0.040 |
Why?
|
| Cell Death | 1 | 2004 | 1695 | 0.040 |
Why?
|
| Psychophysiology | 1 | 1998 | 135 | 0.040 |
Why?
|
| HIV Infections | 2 | 2002 | 16678 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2008 | 2257 | 0.040 |
Why?
|
| COS Cells | 2 | 1999 | 1160 | 0.040 |
Why?
|
| Base Sequence | 5 | 2008 | 12797 | 0.040 |
Why?
|
| Trichotillomania | 1 | 2000 | 172 | 0.040 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2020 | 362 | 0.040 |
Why?
|
| Hemoglobins | 1 | 2004 | 1532 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2000 | 534 | 0.040 |
Why?
|
| Protein Binding | 3 | 2000 | 9387 | 0.040 |
Why?
|
| Endocrine System | 1 | 1998 | 113 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 9 | 2022 | 9274 | 0.040 |
Why?
|
| Histamine H1 Antagonists, Non-Sedating | 1 | 2017 | 15 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 4 | 2001 | 6313 | 0.040 |
Why?
|
| DNA Mutational Analysis | 1 | 2006 | 4187 | 0.040 |
Why?
|
| Alternaria | 1 | 1997 | 44 | 0.040 |
Why?
|
| Cell Survival | 1 | 2007 | 5872 | 0.040 |
Why?
|
| Dermatomycoses | 1 | 1997 | 45 | 0.040 |
Why?
|
| Islet Amyloid Polypeptide | 1 | 1996 | 41 | 0.040 |
Why?
|
| Nitrites | 1 | 2017 | 160 | 0.040 |
Why?
|
| Hippocampus | 1 | 2009 | 3661 | 0.040 |
Why?
|
| Adrenomedullin | 1 | 1996 | 87 | 0.040 |
Why?
|
| Leishmaniasis, Diffuse Cutaneous | 1 | 1996 | 2 | 0.040 |
Why?
|
| Concanavalin A | 1 | 1996 | 191 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2004 | 2211 | 0.040 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 1996 | 255 | 0.040 |
Why?
|
| Cricetinae | 2 | 2011 | 2471 | 0.040 |
Why?
|
| Lung Diseases, Fungal | 1 | 1997 | 122 | 0.030 |
Why?
|
| Isoantigens | 2 | 1996 | 567 | 0.030 |
Why?
|
| Radioisotope Dilution Technique | 1 | 1995 | 70 | 0.030 |
Why?
|
| Bombesin | 1 | 2015 | 34 | 0.030 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 1996 | 248 | 0.030 |
Why?
|
| Endemic Diseases | 1 | 2017 | 182 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 5 | 1984 | 1470 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 2015 | 1969 | 0.030 |
Why?
|
| Zebrafish | 1 | 2007 | 2990 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2020 | 596 | 0.030 |
Why?
|
| Biosensing Techniques | 1 | 2002 | 668 | 0.030 |
Why?
|
| Adult | 9 | 2017 | 213712 | 0.030 |
Why?
|
| Middle Aged | 8 | 2017 | 213127 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2015 | 6365 | 0.030 |
Why?
|
| Leishmaniasis, Visceral | 1 | 1996 | 93 | 0.030 |
Why?
|
| CD4-CD8 Ratio | 1 | 1994 | 112 | 0.030 |
Why?
|
| Indomethacin | 1 | 1995 | 331 | 0.030 |
Why?
|
| Lipolysis | 1 | 2015 | 211 | 0.030 |
Why?
|
| Anticarcinogenic Agents | 1 | 2015 | 253 | 0.030 |
Why?
|
| Disulfides | 1 | 1996 | 457 | 0.030 |
Why?
|
| Quinoxalines | 1 | 2015 | 288 | 0.030 |
Why?
|
| Autoimmune Diseases | 2 | 1987 | 2130 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2017 | 1683 | 0.030 |
Why?
|
| Protein Denaturation | 1 | 2013 | 237 | 0.030 |
Why?
|
| Cell Membrane | 2 | 2009 | 3744 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 2 | 2011 | 2699 | 0.030 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1993 | 293 | 0.030 |
Why?
|
| Autoantibodies | 1 | 1981 | 2036 | 0.030 |
Why?
|
| Genes, MHC Class II | 3 | 1982 | 458 | 0.030 |
Why?
|
| Brazil | 1 | 2017 | 1263 | 0.030 |
Why?
|
| Prednisone | 2 | 1988 | 1567 | 0.030 |
Why?
|
| Thiazolidinediones | 1 | 2015 | 476 | 0.030 |
Why?
|
| Bioprosthesis | 1 | 1997 | 596 | 0.030 |
Why?
|
| Norepinephrine | 1 | 1995 | 909 | 0.030 |
Why?
|
| Ischemic Attack, Transient | 1 | 1998 | 934 | 0.030 |
Why?
|
| Iodine Radioisotopes | 1 | 1995 | 1030 | 0.030 |
Why?
|
| Asthma | 1 | 2010 | 5955 | 0.030 |
Why?
|
| Psychophysics | 1 | 2012 | 309 | 0.030 |
Why?
|
| Pain Threshold | 1 | 2015 | 585 | 0.030 |
Why?
|
| Amyloid | 1 | 1996 | 795 | 0.030 |
Why?
|
| Neuroimmunomodulation | 1 | 1993 | 152 | 0.020 |
Why?
|
| Isoelectric Focusing | 1 | 1991 | 181 | 0.020 |
Why?
|
| Calcium Channel Blockers | 1 | 1995 | 689 | 0.020 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2011 | 225 | 0.020 |
Why?
|
| Electrophoresis | 1 | 1991 | 240 | 0.020 |
Why?
|
| Microscopy, Video | 1 | 2011 | 245 | 0.020 |
Why?
|
| Rhodamines | 1 | 2011 | 183 | 0.020 |
Why?
|
| Species Specificity | 1 | 1995 | 2479 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 1995 | 1525 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 1996 | 1200 | 0.020 |
Why?
|
| Apyrase | 1 | 1993 | 364 | 0.020 |
Why?
|
| Aortic Diseases | 1 | 1997 | 741 | 0.020 |
Why?
|
| Europe | 1 | 2017 | 3339 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 1086 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1995 | 2003 | 0.020 |
Why?
|
| Blood Vessels | 1 | 1996 | 1124 | 0.020 |
Why?
|
| Histocompatibility Antigens | 2 | 1982 | 471 | 0.020 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 1998 | 1016 | 0.020 |
Why?
|
| Aged | 5 | 2017 | 162944 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1987 | 2505 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 2012 | 514 | 0.020 |
Why?
|
| Thionucleotides | 1 | 2009 | 107 | 0.020 |
Why?
|
| Cell Division | 2 | 1996 | 4564 | 0.020 |
Why?
|
| Cattle | 1 | 1995 | 3923 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 3862 | 0.020 |
Why?
|
| Melanosomes | 1 | 2009 | 31 | 0.020 |
Why?
|
| Dextrans | 1 | 2011 | 592 | 0.020 |
Why?
|
| Pyrilamine | 1 | 2009 | 12 | 0.020 |
Why?
|
| Vaccination | 1 | 2002 | 3256 | 0.020 |
Why?
|
| Multigene Family | 1 | 1993 | 1102 | 0.020 |
Why?
|
| Nerve Fibers | 1 | 1993 | 688 | 0.020 |
Why?
|
| Nitroarginine | 1 | 2009 | 66 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 1994 | 1866 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2015 | 960 | 0.020 |
Why?
|
| Arsenites | 1 | 2009 | 66 | 0.020 |
Why?
|
| Cell Separation | 2 | 1993 | 1749 | 0.020 |
Why?
|
| Reaction Time | 1 | 2015 | 2092 | 0.020 |
Why?
|
| Random Amplified Polymorphic DNA Technique | 1 | 2008 | 19 | 0.020 |
Why?
|
| Teratogens | 1 | 2009 | 112 | 0.020 |
Why?
|
| Histamine H1 Antagonists | 1 | 2009 | 100 | 0.020 |
Why?
|
| Bradykinin | 1 | 2009 | 214 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1981 | 2099 | 0.020 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2011 | 675 | 0.020 |
Why?
|
| Random Allocation | 1 | 2013 | 2425 | 0.020 |
Why?
|
| Crosses, Genetic | 4 | 1982 | 791 | 0.020 |
Why?
|
| Action Potentials | 1 | 2015 | 1814 | 0.020 |
Why?
|
| Dogs | 1 | 2013 | 3910 | 0.020 |
Why?
|
| Heart Valve Prosthesis | 1 | 1997 | 1486 | 0.020 |
Why?
|
| Calcinosis | 1 | 1997 | 1497 | 0.020 |
Why?
|
| Mass Spectrometry | 2 | 1996 | 2203 | 0.020 |
Why?
|
| Arterioles | 1 | 2009 | 253 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 1994 | 1606 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2008 | 803 | 0.020 |
Why?
|
| Immunodiffusion | 1 | 1987 | 163 | 0.020 |
Why?
|
| Antibody Specificity | 2 | 1987 | 1094 | 0.020 |
Why?
|
| Indoles | 1 | 2015 | 1834 | 0.020 |
Why?
|
| Hot Temperature | 1 | 2013 | 1355 | 0.020 |
Why?
|
| Cross-Over Studies | 1 | 2012 | 2030 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 1986 | 5662 | 0.020 |
Why?
|
| Neutrophils | 2 | 2011 | 3711 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2009 | 963 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 1987 | 218 | 0.020 |
Why?
|
| Binding Sites | 1 | 1995 | 6115 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 8925 | 0.020 |
Why?
|
| Epitopes | 3 | 1982 | 2569 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2008 | 1581 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2009 | 1135 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2007 | 876 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2002 | 3667 | 0.020 |
Why?
|
| Cytochrome c Group | 2 | 1982 | 128 | 0.020 |
Why?
|
| Peptides | 2 | 1996 | 4392 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2009 | 1902 | 0.020 |
Why?
|
| Plasma | 1 | 2009 | 575 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 4801 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2015 | 3418 | 0.020 |
Why?
|
| Amino Acids | 1 | 1991 | 1727 | 0.020 |
Why?
|
| Vasoconstriction | 1 | 2007 | 596 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2010 | 1460 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1992 | 2126 | 0.020 |
Why?
|
| United States | 2 | 2010 | 69693 | 0.010 |
Why?
|
| Recurrence | 1 | 1996 | 8333 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 1915 | 0.010 |
Why?
|
| Dimethylphenylpiperazinium Iodide | 1 | 2003 | 6 | 0.010 |
Why?
|
| Ganglionic Stimulants | 1 | 2003 | 19 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2008 | 1727 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2015 | 3278 | 0.010 |
Why?
|
| Cholinergic Fibers | 1 | 2003 | 68 | 0.010 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2009 | 1239 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2015 | 35342 | 0.010 |
Why?
|
| Parasympatholytics | 1 | 2003 | 91 | 0.010 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2000 | 4248 | 0.010 |
Why?
|
| Blood Platelets | 1 | 1993 | 2506 | 0.010 |
Why?
|
| Methacholine Chloride | 1 | 2003 | 233 | 0.010 |
Why?
|
| Muscarinic Agonists | 1 | 2003 | 87 | 0.010 |
Why?
|
| Atropine | 1 | 2003 | 244 | 0.010 |
Why?
|
| Receptors, Vasoactive Intestinal Polypeptide, Type I | 1 | 2001 | 4 | 0.010 |
Why?
|
| Receptors, Vasoactive Intestinal Peptide, Type II | 1 | 2001 | 6 | 0.010 |
Why?
|
| RNA | 2 | 2008 | 2747 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 2007 | 1640 | 0.010 |
Why?
|
| Biopsy | 1 | 1994 | 6756 | 0.010 |
Why?
|
| Culture Media, Serum-Free | 1 | 2001 | 158 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 11363 | 0.010 |
Why?
|
| Anesthesia | 1 | 2012 | 1548 | 0.010 |
Why?
|
| Hybrid Cells | 1 | 1981 | 441 | 0.010 |
Why?
|
| Oxygen | 1 | 2012 | 4169 | 0.010 |
Why?
|
| Blood Pressure | 2 | 2012 | 8541 | 0.010 |
Why?
|
| Grooming | 1 | 2000 | 37 | 0.010 |
Why?
|
| Phylogeny | 1 | 2008 | 2797 | 0.010 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 1788 | 0.010 |
Why?
|
| Clone Cells | 2 | 1981 | 1692 | 0.010 |
Why?
|
| Cyclophosphamide | 1 | 1986 | 2236 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 1981 | 918 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 1996 | 12958 | 0.010 |
Why?
|
| Neurosecretory Systems | 1 | 2001 | 231 | 0.010 |
Why?
|
| Enteric Nervous System | 1 | 2003 | 189 | 0.010 |
Why?
|
| Neurites | 1 | 2001 | 380 | 0.010 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 1999 | 220 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1992 | 4214 | 0.010 |
Why?
|
| Dendritic Cells | 1 | 2010 | 2723 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 1999 | 354 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 1982 | 935 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2017 | 21719 | 0.010 |
Why?
|
| Child | 3 | 2015 | 77478 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2008 | 4211 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2001 | 768 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2001 | 11039 | 0.010 |
Why?
|
| Endothelial Cells | 1 | 2011 | 3455 | 0.010 |
Why?
|
| Time Factors | 2 | 2011 | 40054 | 0.010 |
Why?
|
| DNA | 1 | 1992 | 7289 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2015 | 12695 | 0.010 |
Why?
|
| Narcotic Antagonists | 1 | 2002 | 562 | 0.010 |
Why?
|
| Spectrometry, Mass, Fast Atom Bombardment | 1 | 1996 | 31 | 0.010 |
Why?
|
| Models, Psychological | 1 | 2000 | 810 | 0.010 |
Why?
|
| Chymotrypsin | 1 | 1996 | 149 | 0.010 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1999 | 1723 | 0.010 |
Why?
|
| Trypsin | 1 | 1996 | 509 | 0.010 |
Why?
|
| Crohn Disease | 1 | 1988 | 2301 | 0.010 |
Why?
|
| DNA Primers | 1 | 1999 | 2892 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1999 | 1526 | 0.010 |
Why?
|
| Cysteine | 1 | 1999 | 873 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1996 | 682 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2010 | 9410 | 0.010 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 1996 | 503 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 57683 | 0.010 |
Why?
|
| Columbidae | 2 | 1982 | 40 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 1995 | 558 | 0.010 |
Why?
|
| Infant | 1 | 1994 | 35070 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 708 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1994 | 40955 | 0.010 |
Why?
|
| Prosthesis Failure | 1 | 1997 | 1203 | 0.010 |
Why?
|
| Arteries | 1 | 1996 | 1118 | 0.010 |
Why?
|
| Ovalbumin | 1 | 1993 | 719 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1999 | 4013 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 1999 | 1225 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 1996 | 1585 | 0.010 |
Why?
|
| DNA, Protozoan | 1 | 1991 | 237 | 0.010 |
Why?
|
| DNA Probes | 1 | 1991 | 560 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 7721 | 0.000 |
Why?
|
| Antigens, Surface | 2 | 1982 | 1663 | 0.000 |
Why?
|
| Mutation | 1 | 2011 | 29717 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 14720 | 0.000 |
Why?
|
| Saliva | 1 | 1991 | 805 | 0.000 |
Why?
|
| Isoenzymes | 1 | 1991 | 1725 | 0.000 |
Why?
|
| Comorbidity | 1 | 2000 | 10372 | 0.000 |
Why?
|
| Radiography | 1 | 1997 | 7010 | 0.000 |
Why?
|
| Reference Values | 1 | 1993 | 4982 | 0.000 |
Why?
|
| Kidney | 1 | 1981 | 7167 | 0.000 |
Why?
|
| Antigens, Neoplasm | 1 | 1993 | 1983 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 2001 | 11470 | 0.000 |
Why?
|
| Mice, Inbred A | 1 | 1984 | 248 | 0.000 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1984 | 363 | 0.000 |
Why?
|
| Prevalence | 1 | 2000 | 15194 | 0.000 |
Why?
|
| Cognition | 1 | 2000 | 6722 | 0.000 |
Why?
|
| Mice, Inbred C3H | 1 | 1984 | 964 | 0.000 |
Why?
|
| Cross Reactions | 1 | 1984 | 841 | 0.000 |
Why?
|
| Tuberculin | 1 | 1981 | 65 | 0.000 |
Why?
|
| Immunization, Passive | 1 | 1984 | 625 | 0.000 |
Why?
|
| Macrophages | 1 | 1995 | 5655 | 0.000 |
Why?
|
| Mental Disorders | 1 | 2000 | 6587 | 0.000 |
Why?
|
| H-2 Antigens | 1 | 1981 | 365 | 0.000 |
Why?
|
| Heterozygote | 1 | 1982 | 2790 | 0.000 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1984 | 2524 | 0.000 |
Why?
|
| Polymers | 1 | 1981 | 1618 | 0.000 |
Why?
|
| Flow Cytometry | 1 | 1982 | 5975 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1982 | 5519 | 0.000 |
Why?
|
| Genotype | 1 | 1982 | 12946 | 0.000 |
Why?
|